These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24926630)

  • 1. [Pharmacology of Raynaud's phenomenon].
    Roustit M; Khouri C; Blaise S; Villier C; Carpentier P; Cracowski JL
    Therapie; 2014; 69(2):115-28. PubMed ID: 24926630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding, assessing and treating Raynaud's phenomenon.
    Boin F; Wigley FM
    Curr Opin Rheumatol; 2005 Nov; 17(6):752-60. PubMed ID: 16224254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Raynaud's phenomenon].
    Lazareth I
    Ann Dermatol Venereol; 1987; 114(8):1035-8. PubMed ID: 2892456
    [No Abstract]   [Full Text] [Related]  

  • 5. Raynaud's phenomenon (secondary).
    Herrick A
    BMJ Clin Evid; 2008 Sep; 2008():. PubMed ID: 19445801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How I treat...Raynaud's phenomenon].
    Piérard GE
    Rev Med Liege; 1998 Mar; 53(3):119-20. PubMed ID: 9594609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis.
    Botzoris V; Drosos AA
    Joint Bone Spine; 2011 Jul; 78(4):341-6. PubMed ID: 21183379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of Raynaud's phenomenon.
    Levien TL
    Vasc Health Risk Manag; 2010 Mar; 6():167-77. PubMed ID: 20448801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study.
    Lee EY; Park JK; Lee W; Kim YK; Park CS; Giles JT; Park JW; Shin K; Lee JS; Song YW; Lee EB
    Rheumatology (Oxford); 2014 Apr; 53(4):658-64. PubMed ID: 24352340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New lines in therapy of Raynaud's phenomenon.
    Lambova SN; Müller-Ladner U
    Rheumatol Int; 2009 Feb; 29(4):355-63. PubMed ID: 19037602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system mediators and Raynaud's phenomenon.
    Wood HM; Ernst ME
    Ann Pharmacother; 2006 Nov; 40(11):1998-2002. PubMed ID: 17003081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
    Thompson AE; Shea B; Welch V; Fenlon D; Pope JE
    Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Treatment of Raynaud's Phenomenon of the Nipple.
    Anderson PO
    Breastfeed Med; 2020 Nov; 15(11):686-688. PubMed ID: 32700966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Raynaud's phenomenon].
    Zeni S; Ingegnoli F
    Reumatismo; 2004; 56(2):77-81. PubMed ID: 15309214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part II: The treatment of primary and secondary Raynaud's phenomenon.
    Curtiss P; Svigos K; Schwager Z; Lo Sicco K; Franks AG
    J Am Acad Dermatol; 2024 Feb; 90(2):237-248. PubMed ID: 35809802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
    Shcherbakov AB
    Vutr Boles; 1988; 27(6):55-8. PubMed ID: 3247706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.